Index of reports
> Cases with Blood Alkaline Phosphatase Increased (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Roferon-A (Interferon Alfa-2A) where reactions include blood alkaline phosphatase increased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Roferon-A side effects in
Reported by a physician from United States on 2012-08-06
Patient:
Reactions: Weight Decreased, Blood Creatine Phosphokinase Increased, Pyrexia, Cardiac Disorder, Cerebral Haemorrhage, Dyspepsia, DRY Mouth, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, Stomatitis, Intracranial Tumour Haemorrhage, Anaemia, Aspartate Aminotransferase Increased, Neutropenia, Amylase Increased, Myalgia, Fatigue, Blood Uric Acid Increased, Myocardial Infarction, Thrombocytopenia, Decreased Appetite, Dyspnoea, Vomiting, Nausea, Lymphopenia, Alanine Aminotransferase Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Hypophosphataemia, Diarrhoea, Respiratory Failure, Arthralgia, Neoplasm Malignant, Ejection Fraction Decreased, Hypothyroidism, Lipase Increased, Hypertension, Asthenia, Leukopenia, Influenza Like Illness
Adverse event resulted in: death
Drug(s) suspected as cause:
Roferon-A
Dosage: given on nonconsecutive days, 3 mu at three times a week during the first week.
Indication: Metastatic Renal Cell Carcinoma
Roferon-A
Dosage: given 6 mu three times a week during second week.
Roferon-A
Dosage: given 9 mu three times a week thereafter.
Possible Roferon-A side effects in male
Reported by a physician from France on 2012-08-01
Patient: male
Reactions: Blood Alkaline Phosphatase Increased, Hyperkalaemia, Anaemia, Lymphopenia, Bacterial Pyelonephritis, Hyponatraemia, Klebsiella Infection, Renal Failure, Gamma-Glutamyltransferase Increased, Cardiac Failure, Posterior Reversible Encephalopathy Syndrome, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Renal Cancer
Start date: 2011-11-08
End date: 2011-11-08
Roferon-A
Indication: Renal Cancer
Start date: 2011-10-24
End date: 2011-11-21
Other drugs received by patient: Allopurinol; Candesartan Cilexetil; Previscan (France); Proscar; Temerit
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-07-18
Patient: male, weighing 106.8 kg (235.0 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Pneumonia, Anaemia, Pneumonitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Roferon-A
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-07-11
Patient: male, weighing 62.2 kg (136.8 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Hyperbilirubinaemia, Anaemia, Transaminases Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Possible Roferon-A side effects in
Reported by a individual with unspecified qualification from Netherlands on 2012-03-21
Patient:
Reactions: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Calcium Metabolism Disorder, Hypersensitivity, Anaemia, Lymphopenia, Pulmonary Embolism, Hyponatraemia, Pyrexia, Blood Potassium Abnormal, Neoplasm Malignant, Gamma-Glutamyltransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atrasentan
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Roferon-A
Dosage: dose: 9 mu
Indication: Metastatic Renal Cell Carcinoma
|